420 related articles for article (PubMed ID: 9376592)
1. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood.
Qian JX; Lee SM; Suen Y; Knoppel E; van de Ven C; Cairo MS
Blood; 1997 Oct; 90(8):3106-17. PubMed ID: 9376592
[TBL] [Abstract][Full Text] [Related]
2. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells.
Lee SM; Suen Y; Chang L; Bruner V; Qian J; Indes J; Knoppel E; van de Ven C; Cairo MS
Blood; 1996 Aug; 88(3):945-54. PubMed ID: 8704253
[TBL] [Abstract][Full Text] [Related]
3. The regulation and biological activity of interleukin 12.
Lee SM; Suen Y; Qian J; Knoppel E; Cairo MS
Leuk Lymphoma; 1998 May; 29(5-6):427-38. PubMed ID: 9643557
[TBL] [Abstract][Full Text] [Related]
4. Effect of interleukin-15 and Flt3-ligand on natural killer cell expansion and activation: umbilical cord vs. adult peripheral blood mononuclear cells.
Lin SJ; Yang MH; Chao HC; Kuo ML; Huang JL
Pediatr Allergy Immunol; 2000 Aug; 11(3):168-74. PubMed ID: 10981526
[TBL] [Abstract][Full Text] [Related]
5. Immaturity of IL-18 gene expression and protein production in cord blood (CB) versus peripheral blood (PB) mononuclear cells and differential effects in natural killer (NK) cell development and function.
Satwani P; Ayello J; Ven C; O'Neill AF; Simpson LL; Baxi L; Cairo MS
Br J Haematol; 2005 Jul; 130(2):284-92. PubMed ID: 16029458
[TBL] [Abstract][Full Text] [Related]
6. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of lymphokine production in the neonate and its impact on neonatal cell mediated immunity.
Suen Y; Lee SM; Qian J; van de Ven C; Cairo MS
Vaccine; 1998; 16(14-15):1369-77. PubMed ID: 9711774
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic changes of T-lymphocyte subsets induced by interleukin-12 and interleukin-15 in umbilical cord vs. adult peripheral blood mononuclear cells.
Lin SJ; Chao HC; Yan DC
Pediatr Allergy Immunol; 2001 Feb; 12(1):21-6. PubMed ID: 11251861
[TBL] [Abstract][Full Text] [Related]
9. Functional analyses of cord blood natural killer cells and T cells: a distinctive interleukin-18 response.
Nomura A; Takada H; Jin CH; Tanaka T; Ohga S; Hara T
Exp Hematol; 2001 Oct; 29(10):1169-76. PubMed ID: 11602318
[TBL] [Abstract][Full Text] [Related]
10. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes.
Krampera M; Tavecchia L; Benedetti F; Nadali G; Pizzolo G
Haematologica; 2000 Jul; 85(7):675-9. PubMed ID: 10897117
[TBL] [Abstract][Full Text] [Related]
11. The effect of interleukin-12 and interleukin-15 on CD69 expression of T-lymphocytes and natural killer cells from umbilical cord blood.
Lin SJ; Chao HC; Kuo ML
Biol Neonate; 2000 Oct; 78(3):181-5. PubMed ID: 11044766
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of superior anti-tumor cytotoxic response of interleukin 15-induced lymphokine-activated killer cells.
Ozdemir O; Ravindranath Y; Savaşan S
J Immunother; 2005; 28(1):44-52. PubMed ID: 15614044
[TBL] [Abstract][Full Text] [Related]
14. IL-2-activated cord blood mononuclear cells.
Derzic S; Slone V; Sender L
Cytotherapy; 2005; 7(5):408-16. PubMed ID: 16236630
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cytotoxic function and apoptosis in interleukin (IL)-12/IL-15-treated umbilical cord or adult peripheral blood natural killer cells by a propidium-iodide based flow cytometry.
Lin SJ; Cheng PJ; Huang YJ; Kuo ML
Pediatr Allergy Immunol; 2004 Feb; 15(1):79-85. PubMed ID: 14998386
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-15 enhances CD4(+) CD45RA(+) expression on umbilical cord blood mononuclear cells.
Lin SJ; Chao HC
Pediatr Allergy Immunol; 2001 Aug; 12(4):188-93. PubMed ID: 11555315
[TBL] [Abstract][Full Text] [Related]
17. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
[TBL] [Abstract][Full Text] [Related]
18. Biologic response modulation by tumor necrosis factor alpha (TNF alpha) in a phase Ib trial in cancer patients.
Logan TF; Gooding WE; Whiteside TL; Ernstoff MS; Kaplan SS; Miketic L; Vlock DR; Tompkins C; Wood DL; Nadler PI; Kirkwood JM
J Immunother; 1997 Sep; 20(5):387-98. PubMed ID: 9336746
[TBL] [Abstract][Full Text] [Related]
19. Effects of tumour necrosis factor-alpha (TNF-alpha), IL-1 beta and monocytes on lymphokine-activated killer (LAK) induction from natural killer (NK) cells and T lymphocytes.
Yoneda K; Osaki T; Yamamoto T; Ueta E
Clin Exp Immunol; 1993 Aug; 93(2):229-36. PubMed ID: 8348749
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxicity of human cord blood natural killer cells is enhanced by recombinant interleukin-15.
Saghafi S; Pourfathollah AA; Kheirandish M; Azimdoust A; Behnia M; Shahjahani M; Moin M
Iran J Allergy Asthma Immunol; 2010 Jun; 9(2):69-77. PubMed ID: 20683100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
